[1]
S, M. and KUMAR M, K. 2024. PERSPECTIVES OF CLINICAL EXPERTS ON THE CURRENT USAGE PATTERNS AND THE PREFERENCE OF VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES. Innovare Journal of Medical Sciences. 12, 2 (Mar. 2024), 1–3. DOI:https://doi.org/10.22159/ijms.2024.v12i2.50211.